ArticleBMJ digital health & AI2026
Mixed-methods evaluation of clinician experiences and adoption patterns of an EHR-integrated generative AI-based clinical decision support uptake by clinicians in Kenya.
Article in BMJ digital health & AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial.Nature medicine · 2026Trial
- AI is already in the theatre of war just not on the side of the patient: clinical chatbots, telemedicine, and an agenda for "AI for medical humanity".Frontiers in digital health · 2026Article
- Safety of a large language model-based clinical decision support system in African primary healthcare.Nature health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To quantify the patterns of uptake of a large language model (LLM)-based clinical decision support system across private primary health facilities in Kenya (operated by Penda Health) and explore factors influencing clinician uptake and overall experience. Methods and analysis: A mixed-methods study combining quantitative analysis of clinical decision support system (CDSS) metadata from all consultations that took place between 1 February and 1 October 2024, augmented by qualitative data from 42 staff members (26 clinical officers, 10 facility managers, 4 nurses, 1 quality assurance manager and 1 business analyst). Data collection included journey mapping interviews (n=7), user-experience interviews (n=25), focus groups (n=2) and system utilisation metrics. Quantitative data were summarised using descriptive statistics, and qualitative data were analysed using thematic analysis (drawing on established theories of technology adoption and change management). Results: In total, there were 258 106 clinical episodes across all Penda Health facilities over the 8-month observation period, of which 56 050 (21.7%) were augmented by use of the 'artificial intelligence (AI) Consult'. 'AI Consult' use aggregated across the 16 facilities increased from 4% to 47% over 8 months. Clinicians provided feedback on their experience using the AI Consult in 31% of the clinical episodes; nearly all the feedback provided (99.5%) was positive. The qualitative investigation identified five key themes associated with clinicians' experiences with the AI Consult tool: (1) there are several value propositions to an 'AI Consult' style tool, (2) clinicians' confidence in the AI Consult grew with time, (3) clinicians' application of the 'AI Consult' is influenced by case complexity, (4) responses from the AI Consult are largely believed and valued by clinicians but several improvements are recommended and (5) clinicians find the 'AI Consult' easy to use but identified several pain points that warrant attention. Conclusion: Successful generative AI/LLM-enhanced CDSS implementation in resource-constrained settings requires: (1) robust technological infrastructure, (2) localisation to reflect clinical guidelines, (3) structured change management with clinical champions and (4) seamless workflow integration. Future product development exercises should specifically consider alternatives to active solicitation of CDSS input, as it is liable to overconfidence-related underutilisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.